[Hytest] 감염병 진단 - Empowering Infectious Disease Diagnostics with Trust…
페이지 정보
작성자 모비트코리아 댓글 0건 조회 64회 작성일 25-05-29 10:50본문
New HIV p24 Antibodies Launched
New Recombinant HCV NS3 Antigen
Our comprehensive offering now includes solutions for Influenza A & B, SARS-CoV-2, RSV, Hepatitis B, HPV, HIV, HCV and many others. Each reagent is manufactured to meet the highest standards of quality and performance. Explore below to find more!
Influenza A and B
Seasonal influenza affects millions each year, with Influenza A being responsible for global outbreaks and Influenza B for regional epidemics. Early and accurate detection is essential for timely treatment and containment. Our products target key viral proteins to support the development of sensitive rapid tests and lab-based assays.
SARS-CoV-2
The virus behind COVID-19 has reshaped public health and diagnostic landscapes. With ongoing variants and long-term surveillance needs, dependable reagents are vital. Our SARS-CoV-2 product line includes high-affinity antibodies and antigens designed for immunoassay development.
Respiratory Syncytial Virus (RSV)
A leading cause of lower respiratory tract infections in infants and older adults, RSV presents a serious seasonal challenge. Rapid, point-of-care diagnosis can significantly reduce hospitalizations. Our RSV reagents support assay development for both clinical and surveillance applications.
Hepatitis B Virus
A global burden with over 250 million chronic carriers, hepatitis B can lead to severe liver disease, including cirrhosis and cancer. Early detection of HBV antigens and antibodies is crucial for screening, vaccination monitoring, and treatment decisions. We offer well-characterized reagents for HBV assay development.
Human papillomavirus (HPV)
A major cause of cervical and other cancers, HPV often progresses silently without early detection. Accurate diagnostics are key to prevention and early intervention. Our HPV antigens and antibodies are optimized for immunoassay-based detection platforms.
Human Immunodeficiency Virus (HIV)
Despite advances in treatment, HIV remains a major global health concern. Reliable diagnosis is critical for prevention, early care, and managing transmission. Our newly expanded HIV portfolio now includes high-quality antibodies, offering robust tools for both screening and confirmatory diagnostics.
댓글목록
등록된 댓글이 없습니다.